Breaking News Instant updates and real-time market news.

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

, NKE

Nike

$95.61

-0.61 (-0.63%)

07:40
10/23/19
10/23
07:40
10/23/19
07:40

ServiceNow new CEO well-suited for next growth phase, says Cowen

Cowen analyst J. Derrick Wood noted ServiceNow (NOW) announced its CEO would be leaving to be CEO of Nike (NKE) and that ex-SAP (SAP) CEO Bill McDermott will take his place. The company also preannounced its Q3 results, beating estimates on billings growth and raising guidance on the high-end. The analyst noted the CEO change was a surprise but he believes McDermott's skill set should be well-suited for the company's next growth phase. Wood reiterated his Outperform rating and $315 price target on ServiceNow shares.

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

NKE

Nike

$95.61

-0.61 (-0.63%)

SAP

SAP

$131.78

-0.91 (-0.69%)

  • 23

    Oct

  • 19

    Nov

  • 09

    Dec

  • 12

    Dec

NOW ServiceNow
$228.26

-12.315 (-5.12%)

10/23/19
MACQ
10/23/19
NO CHANGE
Target $243
MACQ
Outperform
Macquarie a buyer of ServiceNow, says Bill McDermott a 'huge win'
Macquarie analyst Sarah Hindlian says that while she understands the uncertainty in ServiceNow shares around the departure of John Donahoe and the lack of a CFO appointment, she thinks the preliminary results "spoke volumes against the bear case." Further, the analyst sees incoming CEO Bill McDermott "as one of the best executives available in enterprise software." McDermott is a "huge win," contends Hindlian, who is a buyer of ServiceNow shares into today's conference call. She has a Buy rating on the stock with a $335 price target.
10/23/19
UBSW
10/23/19
NO CHANGE
Target $232
UBSW
Buy
ServiceNow stock price attractive following aftermarket decline, says UBS
UBS analyst Jennifer Lowe is keeping her Buy rating and $232 price target on ServiceNow (NOW) after the stock fell afterhours yesterday on the news that its CEO John Donahoe is leaving for a CEO post at Nike (NKE). The analyst notes that the company also pre-announced Q3 ahead of consensus while its FY19 outlook indicates no change to Q4 guidance. Lowe adds that although ServiceNow is faced with new CEO transition risk, the former SAP CEO Bill McDermott is also "seasoned", and the stock is "attractive" at a 29-times enterprise value to expected 2020 free cash flow.
10/23/19
JEFF
10/23/19
NO CHANGE
Target $330
JEFF
Buy
ServiceNow shares may remain range-bound, says Jefferies
While ServiceNow's preliminary Q3 results beat subscriber billings expectations, the implied Q4 subscription revenue and billings guidance were both below consensus, Jefferies analyst Samad Samana tells investors in a research note. The analyst is not sure the Q3 results will be enough to drive shares higher in the near-term given the implied Q4 guidance, the uncertainty created by ServiceNow's leadership changes, and concerns facing high-growth software. However, he sees Bill McDermott as a "solid" CEO hire given his "successful track record in enterprise software." Samana keeps a Buy rating on ServiceNow shares with a $330 price target.
NKE Nike
$95.61

-0.61 (-0.63%)

10/18/19
FBCO
10/18/19
NO CHANGE
Target $112
FBCO
Outperform
Nike price target raised to $112 from $105 at Credit Suisse
Credit Suisse analyst Michael Binetti raised his price target for Outperform-rated Nike to $112 from $105, saying accelerating global revenue trends and better SG&A leverage should translate to accelerating EPS upside through FY20 and into FY21. Binetti calls Nike's innovation pipeline "the strongest we've seen in years."
10/14/19
10/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Neutral from Underperform at BofA/Merrill with analyst Robert Ohmes saying that he expects the "accelerated democratization" of the brand to offset the broader future challenges around "significant" third-party retail store closures and global stagnation in "performance" footwear/apparel. 2. Western Digital (WDC) upgraded to Buy from Hold at Loop Capital with analyst Ananda Baruah citing his findings that flash memory average selling prices are set to increase starting in the September and December quarters while also sustaining those increases in 2020, along with expectations of strong hyperscale HDD demand next year. 3. Varian Medical (VAR) upgraded to Buy from Neutral at BTIG with analyst Sean Lavin saying Varian shares have pulled back in recent weeks and now trade in line with the comp group. 4. Xilinx (XLNX) upgraded to Buy from Neutral at Nomura Instinet with analyst David Wong saying many risks remain for U.S. semiconductor companies, including uncertainties related to U.S./China trade issues and U.S. action against Chinese companies such as Huawei. 5. HP Enterprise (HPE) upgraded to In Line from Underperform at Evercore ISI with analyst Amit Daryanani saying he is incrementally more positive on cash flow resiliency, the Cray acquisition, recent data points that indicate H3C is performing better than other OEMs in China, and valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/23/19
WEDB
10/23/19
NO CHANGE
Target $100
WEDB
Outperform
Nike new CEO 'has large sneakers to fill,' says Wedbush
Wedbush analyst Christopher Svezia notes that John Donahoe will succeed Mark Parker as President and CEO of Nike at a time when the company is leading consumer industry innovation and shares are at all time highs. Donahoe will have "large sneakers to fill" in January 2020 in taking over responsibilities from Parker, who implemented the successful Triple Double and Consumer Direct Offense strategies that have kept Nike far ahead of the competition while expanding the athletic footwear and apparel market and driving consumer industry innovation, he contends. Overall, Svezia believes Donahoe appears to be "a formidable choice" to lead Nike and may help further accelerate its digital and general market dominance. He has an Outperform rating and $100 price target on the shares.
SAP SAP
$131.78

-0.91 (-0.69%)

07/22/19
JEFF
07/22/19
INITIATION
Target $155
JEFF
Buy
SAP initiated with a Buy at Jefferies
Jefferies analyst Julian Serafini started SAP with a Buy rating and $155 price target. The company is benefiting from the S/4HANA upgrade cycle, resulting in a multi-billion euro incremental revenue opportunity, Serafini tells investors in a research note. Further, its guidance of 500 basis point operating margin improvement by 2023 "appears easily achievable, with the majority stemming from cloud improvements alone," adds the analyst.
10/11/19
JEFF
10/11/19
NO CHANGE
JEFF
Buy
Jefferies keeps Buy rating on SAP after 'sudden' CEO departure
The departure of SAP CEO Bill McDermott, who oversaw a number of transformational acquisitions, is sudden, Jefferies analyst Julian Serafini tells investors in a research note. However, the appointment of Jennifer Morgan and Christian Klein as co-CEOs "is a sign of continuity and they emphasized a focus on organic development," adds the analyst. As such, Serafini believes the leadership change is unlikely to affect SAP's operational execution, and the analyst sees the company's better than expected Q3 results as supportive of this thesis. Serafini keeps a Buy rating on SAP shares.
10/21/19
JEFF
10/21/19
NO CHANGE
Target $156
JEFF
Buy
SAP price target raised to $156 after 'positive' Q3 at Jefferies
Jefferies analyst Julian Serafini raised his price target for SAP (SAP) shares to $156 from $152 saying the company's Q3 results were "positive." The announced partnership with Microsoft (MSFT) provides new go-to-market opportunities and the global sales pipeline remains strong despite select regional slowdowns, Serafini tells investors in a research note. The analyst keeps a Buy rating on SAP.

TODAY'S FREE FLY STORIES

FB

Facebook

$196.73

1.66 (0.85%)

14:01
11/18/19
11/18
14:01
11/18/19
14:01
Options
Call volume jumps in Facebook as shares and implied volatility lift »

Call volume jumps in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ABMD

Abiomed

$190.75

-32.48 (-14.55%)

13:54
11/18/19
11/18
13:54
11/18/19
13:54
Hot Stocks
Abiomed falls after studies question Impella heart device at AHA 2019 meeting »

In a story out over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNI

McClatchy

$0.56

0.0846 (17.63%)

13:53
11/18/19
11/18
13:53
11/18/19
13:53
Hot Stocks
Bluestone Financial raises stake in McClatchy to 11.85% »

Bluestone Financial holds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSII

Heidrick & Struggles

$29.39

-0.04 (-0.14%)

13:50
11/18/19
11/18
13:50
11/18/19
13:50
Initiation
Heidrick & Struggles initiated  »

Heidrick & Struggles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

13:50
11/18/19
11/18
13:50
11/18/19
13:50
General news
Fed's Mester said she would have preferred to have kept rates steady »

Fed's Mester said…

CL

Colgate-Palmolive

$67.08

0.71 (1.07%)

13:45
11/18/19
11/18
13:45
11/18/19
13:45
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRTX

Karuna Therapeutics

$73.20

55.94 (324.10%)

13:43
11/18/19
11/18
13:43
11/18/19
13:43
Recommendations
Karuna Therapeutics analyst commentary  »

Karuna Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

STNE

StoneCo

$37.17

-0.73 (-1.93%)

13:35
11/18/19
11/18
13:35
11/18/19
13:35
Options
StoneCo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

13:35
11/18/19
11/18
13:35
11/18/19
13:35
General news
Treasury Action: yields remain modestly lower on the day »

Treasury Action: yields…

I

Intelsat

$11.26

-2.14 (-15.97%)

13:29
11/18/19
11/18
13:29
11/18/19
13:29
Hot Stocks
CBA responds to announcement by FCC Chair regarding C-band spectrum proceeding »

The C-Band Alliance, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ARWR

Arrowhead

$48.38

0.95 (2.00%)

13:27
11/18/19
11/18
13:27
11/18/19
13:27
Recommendations
Arrowhead analyst commentary  »

Arrowhead data validates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.27

-0.27 (-0.61%)

13:25
11/18/19
11/18
13:25
11/18/19
13:25
Hot Stocks
Altitude Sports files antitrust suit against Comcast »

Altitude Sports &…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.27

-0.27 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EQT

EQT Corporation

$9.70

-0.64 (-6.19%)

13:25
11/18/19
11/18
13:25
11/18/19
13:25
Options
EQT Corporation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

AGIO

Agios Pharmaceuticals

$36.81

1.17 (3.28%)

, ETNB

89bio

$27.29

1.26 (4.84%)

13:25
11/18/19
11/18
13:25
11/18/19
13:25
On The Fly
Fly Insider: 89Bio, Addus Homecare among week's notable insider trades »

Welcome to "Fly Insider,"…

AGIO

Agios Pharmaceuticals

$36.81

1.17 (3.28%)

ETNB

89bio

$27.29

1.26 (4.84%)

GRTX

Galera Therapeutics

$12.06

0.11 (0.92%)

ARVN

Arvinas

$31.31

0.89 (2.93%)

TRN

Trinity Industries

$20.92

-0.295 (-1.39%)

ADUS

Addus HomeCare

$85.34

1.07 (1.27%)

AL

Air Lease

$44.90

-0.58 (-1.28%)

AMED

Amedisys

$155.36

2.65 (1.74%)

BLKB

Blackbaud

$83.98

0.23 (0.27%)

BOKF

BOK Financial

$81.03

-0.88 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

  • 13

    Dec

ZEN

Zendesk

$76.48

1.05 (1.39%)

13:22
11/18/19
11/18
13:22
11/18/19
13:22
Hot Stocks
Helpshift announces integration with Amazon Connect »

Helpshift announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

  • 11

    Dec

MO

Altria Group

$48.47

0.5 (1.04%)

13:19
11/18/19
11/18
13:19
11/18/19
13:19
Hot Stocks
California sues Juul for lack of oversight on sales to minors »

California Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/18/19
11/18
13:17
11/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

I

Intelsat

$11.33

-2.07 (-15.45%)

13:16
11/18/19
11/18
13:16
11/18/19
13:16
Hot Stocks
Eutelsat says 'looks forward to engaging' with FCC on C-band spectrum plans »

Eutelsat Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/18/19
11/18
13:16
11/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$238.09

0.75 (0.32%)

, MDT

Medtronic

$112.01

-0.1 (-0.09%)

13:15
11/18/19
11/18
13:15
11/18/19
13:15
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HD

Home Depot

$238.09

0.75 (0.32%)

MDT

Medtronic

$112.01

-0.1 (-0.09%)

TJX

TJX

$59.34

-0.45 (-0.75%)

TDG

TransDigm

$565.71

7.2 (1.29%)

ARMK

Aramark

$43.66

0.01 (0.02%)

KSS

Kohl's

$58.49

-0.61 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 05

    Dec

  • 11

    Dec

WWD

Woodward

$113.93

-0.86 (-0.75%)

, BILI

Bilibili

$16.50

-0.21 (-1.26%)

13:15
11/18/19
11/18
13:15
11/18/19
13:15
Earnings
Notable companies reporting after market close »

Notable companies…

WWD

Woodward

$113.93

-0.86 (-0.75%)

BILI

Bilibili

$16.50

-0.21 (-1.26%)

ASH

Ashland

$79.01

0.39 (0.50%)

CCMP

Cabot Microelectronics

$135.97

-19.92 (-12.78%)

KRNT

Kornit Digital

$33.05

-1.15 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 06

    Dec

ABMD

Abiomed

$197.70

-25.53 (-11.44%)

13:15
11/18/19
11/18
13:15
11/18/19
13:15
Options
Abiomed put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$143.76

-0.555 (-0.38%)

13:11
11/18/19
11/18
13:11
11/18/19
13:11
Periodicals
AHAM reports October shipments down 11.9% year-over-year, Bloomberg says »

The Association of Home…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$48.47

0.5 (1.04%)

13:11
11/18/19
11/18
13:11
11/18/19
13:11
Hot Stocks
California announces lawsuit against Juul for marketing to teens »

Altria (MO) owns a 35%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

VRTX

Vertex

$209.31

-0.66 (-0.31%)

, CRSP

Crispr Therapeutics

$58.25

1.44 (2.53%)

13:06
11/18/19
11/18
13:06
11/18/19
13:06
Recommendations
Vertex, Crispr Therapeutics analyst commentary  »

Piper says Vertex…

VRTX

Vertex

$209.31

-0.66 (-0.31%)

CRSP

Crispr Therapeutics

$58.25

1.44 (2.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.